BELTSVILLE, Md., Aug 12, 2004 /PRNewswire-FirstCall via COMTEX/ -- Spherix Incorporated (SPEX) today announced that the world's first tagatose-containing chocolate, Miada(R) ChocoLite(R), is very low in Glycemic Load (GL) and estimated relative Glycemic Index (GI), according to newly performed studies. Miada Corporation Limited's recent press release http://www.miadasport.com/chocolite/chocolite-low-carb-chocolate-research.htm, stated that research commissioned by Miada and conducted by leading nutrition researcher Dr. Alison Wallace at the New Zealand Institute for Crop & Food Research Ltd., showed that the chocolate tested had a GL of 1 and an estimated GI of 8. Readings below 10 for GL and below 55 for GI are considered low. Earlier this year, Sydney University's Glycaemic Index Research Service (SUGiRS) tested tagatose in a research study and stated that, compared to glucose, which had glycemic and insulinaemic responses of 100%, tagatose produced very low glycemic and insulinaemic responses of only 3%.
Miada(R) ChocoLite(R) is the world's first chocolate to undergo GL testing, believed to be the most scientifically accurate way to inform consumers of how the recommended serving size of a particular food affects blood glucose levels relative to glucose sugar. This is particularly important to individuals wishing to eat healthier and reduce the amount of insulin the body produces, which may affect conditions such as the onset of Type 2 diabetes and obesity. The study found that, when tagatose, which produces zero glucose, was used, a recommended serving of 25-grams of Miada(R) ChocoLite(R) dark chocolate produced an equivalent blood glucose response of only 1-gram of glucose sugar. Miada(R) ChocoLite(R) also has significantly fewer calories than standard chocolate. Sales of these products are expected to begin in New Zealand and Australia later this year. For more information, please visit Miada's websites at http://www.miadasport.com or http://www.chocolite.co.nz.
Tagatose tastes and acts like table sugar, and can be used as a sugar replacement, or to improve the mouthfeel, sweetness, and flavor profile of products containing high-intensity sweeteners. With the growing worldwide market for low glycemic healthy food and beverages, tagatose provides new and exciting opportunities for developing products that have a low-glycemic effect and have a great taste. Additional benefits of tagatose include its documented prebiotic effect, a food characteristic increasingly sought as an aid to colon health; and its FDA-recognized tooth friendliness.
In 1996, Arla Foods Ingredients licensed the exclusive worldwide rights to produce and commercialize tagatose for use in foods and beverages from Spherix. Arla and Nordzucker, a German sugar producer, have formed a joint venture company named SweetGredients to manufacture and market it under the brand name Gaio(R) tagatose. SweetGredients is today the only worldwide producer of Gaio(R) tagatose. The first commercial production of tagatose was announced in May 2003. The product is being distributed in the U.S. by Arla Foods Ingredients located in New Jersey. For more information on the food and beverage uses of tagatose, see Arla's http://www.gaio-tagatose.com website.
Certain statements contained herein are "forward looking" statements as defined in the Private Securities Litigation Reform Act of 1995. Because such statements include risks and uncertainties, actual results may differ materially from those expressed or implied. Factors that could cause actual results to differ materially from those expressed or implied include, but are not limited to, those discussed in filings by the Company with the Securities and Exchange Commission, including the filing on Form 8-K made on March 3, 1999.
Under its motto, "A World of Solutions," Spherix's mission is to create value and increase shareholder wealth through innovations that benefit our clients and the human condition. Spherix offers innovations in information technology, knowledge management, and biotechnology.